TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15383523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF‐κB

  2004cited by this paper
• A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

  2004cited by this paper
• Schnurri-3 (KRC) Interacts with c-Jun to Regulate the IL-2 Gene in T Cells

  2004cited by this paper
• A flow cytometric method to detect protein‐protein interaction in living cells by directly visualizing donor fluorophore quenching during CFP→YFP fluorescence resonance energy transfer (FRET)

  2003cited by this paper
• Flow cytometric measurement of fluorescence (Förster) resonance energy transfer from cyan fluorescent protein to yellow fluorescent protein using single‐laser excitation at 458 nm

  2003cited by this paper
• The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

  2003cited by this paper
• CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members

  2003cited by this paper
• TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway.

  2003cited by this paper
• Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling*

  2003cited by this paper
• TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.

  2003cited by this paper
• Lipid rafts are important for the association of RANK and TRAF6

  2003cited by this paper
• Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser

  2003cited by this paper
• Tumor Necrosis Factor (TNF)-induced Germinal Center Kinase-related (GCKR) and Stress-activated Protein Kinase (SAPK) Activation Depends upon the E2/E3 Complex Ubc13-Uev1A/TNF Receptor-associated Factor 2 (TRAF2)*

  2003cited by this paper
• Inhibition of NF-kappaB by ZAS3, a zinc-finger protein that also binds to the kappaB motif.

  2003cited by this paper
• TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors.

  2003cited by this paper
• T3JAM, a novel protein that specifically interacts with TRAF3 and promotes the activation of JNK 1

  2003cited by this paper
• Generation and Analysis of Siah2 Mutant Mice

  2003cited by this paper
• OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent 1

  2003cited by this paper
• Structurally Distinct Recognition Motifs in Lymphotoxin-β Receptor and CD40 for Tumor Necrosis Factor Receptor-associated Factor (TRAF)-mediated Signaling*

  2003cited by this paper
• Structurally adaptive hot spots at a protein interaction interface on TRAF3

  2002cited by this paper
• Regulation of the Subcellular Localization of Tumor Necrosis Factor Receptor–associated Factor (TRAF)2 by TRAF1 Reveals Mechanisms of TRAF2 Signaling

  2002cited by this paper
• Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation.

  2002cited by this paper
• A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2.

  2002cited by this paper
• Crystallization and preliminary X-ray analysis of the TRAF domain of TRAF3.

  2002cited by this paper
• Stress‐induced decrease in TRAF2 stability is mediated by Siah2

  2002cited by this paper
• Role of TRAF3 and -6 in the Activation of the NF-κB and JNK Pathways by X-linked Ectodermal Dysplasia Receptor*

  2002cited by this paper
• Cutting Edge: Profound Defect in T Cell Responses in TNF Receptor-Associated Factor 2 Dominant Negative Mice1

  2002cited by this paper
• Differential Signaling and Tumor Necrosis Factor Receptor–Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1)

  2001cited by this paper
• A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study.

  2001cited by this paper
• Caspase‐mediated cleavage of TRAF3 in FasL‐stimulated Jurkat‐T cells

  2001cited by this paper
• Expression and function of TRAF-3 splice-variant isoforms in human lymphoma cell lines.

  2001cited by this paper
• CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation.

  2001cited by this paper
• Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.

  2000cited by this paper
• Discrete Signaling Regions in the Lymphotoxin-β Receptor for Tumor Necrosis Factor Receptor-associated Factor Binding, Subcellular Localization, and Activation of Cell Death and NF-κB Pathways*

  2000cited by this paper
• Membrane Localization of TRAF 3 Enables JNK Activation*

  2000cited by this paper
• TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-κB, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase1

  2000cited by this paper
• CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms.

  2000cited by this paper
• Recruitment of CD40 and Tumor Necrosis Factor Receptor-associated Factors 2 and 3 to Membrane Microdomains during CD40 Signaling*

  2000cited by this paper
• Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.

  2000cited by this paper
• Solution structure of N-TRADD and characterization of the interaction of N-TRADD and C-TRAF2, a key step in the TNFR1 signaling pathway.

  2000cited by this paper
• High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.

  1999cited by this paper
• TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses.

  1999cited by this paper
• TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation.

  1999cited by this paper
• Differential Requirements for Tumor Necrosis Factor Receptor-associated Factor Family Proteins in CD40-mediated Induction of NF-κB and Jun N-terminal Kinase Activation*

  1999cited by this paper
• Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain.

  1999cited by this paper
• TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.

  1998cited by this paper
• Tumor Necrosis Factor Receptor (TNFR)-associated Factor 2A (TRAF2A), a TRAF2 Splice Variant with an Extended RING Finger Domain That Inhibits TNFR2-mediated NF-κB Activation*

  1998cited by this paper
• 4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF)-Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor κB

  1998cited by this paper
• CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.

  1998cited by this paper
• An Intact Zinc Ring Finger Is Required for Tumor Necrosis Factor Receptor-associated Factor-mediated Nuclear Factor-κB Activation but Is Dispensable for c-Jun N-terminal Kinase Signaling*

  1998cited by this paper
• TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.

  1997cited by this paper
• Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.

  1997cited by this paper
• Anatomy of TRAF2

  1996cited by this paper
• Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses.

  1996cited by this paper
• TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

  1995cited by this paper
• A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.

  1994cited by this paper

• PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer

  2024cites this paper
• Adipocyte microRNA-802 promotes adipose tissue inflammation and insulin resistance by modulating macrophages in obesity

  2024cites this paper
• TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes

  2023cites this paper
• FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes

  2023cites this paper
• Interaction of human CRX and NRL in live HEK293T cells measured using fluorescence resonance energy transfer (FRET)

  2022cites this paper
• TRAF5 splicing variants associate with TRAF3 and RIP1 in NF-κB and type I IFN signaling in large yellow croaker Larimichthys crocea.

  2022cites this paper
• Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness

  2022cites this paper
• SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases

  2021cites this paper
• Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases.

  2021cites this paper
• The cardiac molecular setting of metabolic syndrome in pigs reveals disease susceptibility and suggests mechanisms that exacerbate COVID-19 outcomes in patients

  2021cites this paper
• Roles of TRAFs in Ischemia-Reperfusion Injury

  2020cites this paper
• Expression and functional analysis of tumor necrosis factor receptor (TNFR)-associated factor 5 from Nile tilapia, Oreochromis niloticus.

  2019cites this paper
• Recognition of TRAIP with TRAFs: current understanding and associated diseases.

  2019cites this paper
• Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation.

  2019cites this paper
• CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs

  2018cites this paper
• Roles of TRAFs in NF-κB signaling pathways mediated by BAFF.

  2018cites this paper
• miR-155-5p is Negatively Associated with Acute Pancreatitis and Inversely Regulates Pancreatic Acinar Cell Progression by Targeting Rela and Traf3

  2018cites this paper
• TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation

  2018cites this paper
• MicroRNA‐3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip‐α, by targeting TRAF3

  2017cites this paper
• NDR1 protein kinase promotes IL‐17‐ and TNF‐α‐mediated inflammation by competitively binding TRAF3

  2017cites this paper
• TRAF3 as a powerful and multitalented regulator of lymphocyte functions

  2016cites this paper
• Adapter proteins regulate insulin resistance and lipid metabolism in obesity

  2016cites this paper
• TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.

  2016cites this paper
• Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity.

  2015cites this paper
• Global quantitative proteomic analysis of human glioma cells profiled host protein expression in response to enterovirus type 71 infection

  2015cites this paper
• Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity

  2015cites this paper
• Metabolic Control by Inflammation and Immunity Myeloid cell TRAF 3 promotes metabolic inflammation , insulin resistance , and hepatic steatosis in obesity

  2015cites this paper
• TRAF5 Negatively Regulates TLR Signaling in B Lymphocytes

  2014cites this paper
• Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma.

  2014cites this paper
• TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2.

  2014cites this paper
• Activation-induced Tumor Necrosis Factor Receptor-associated Factor 3 (Traf3) Alternative Splicing Controls the Noncanonical Nuclear Factor κB Pathway and Chemokine Expression in Human T Cells*

  2014cites this paper
• Mechanisms of TLR signaling and cooperation in B lymphocytes

  2014cites this paper
• Quantification of Förster resonance energy transfer by monitoring sensitized emission in living plant cells

  2013cites this paper
• Involvement of A20 in the molecular switch that activates the non-canonical NF-кB pathway

  2013cites this paper
• Fumaric acid attenuates the eotaxin-1 expression in TNF-α-stimulated fibroblasts by suppressing p38 MAPK-dependent NF-κB signaling.

  2013cites this paper
• A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes

  2013cites this paper
• Up-regulation and Pre-activation of TRAF3 and TRAF5 in Inflammatory Bowel Disease

  2013cites this paper
• Inducible Tumor Necrosis Factor (TNF) Receptor-associated Factor-1 Expression Couples the Canonical to the Non-canonical NF-κB Pathway in TNF Stimulation*

  2013cites this paper
• Hantavirus Regulation of Type I Interferon Responses

  2012cites this paper
• HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia

  2012cites this paper
• Hepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses

  2012cites this paper
• TRAF2 docking with related proteins in silico studies.

  2012cites this paper
• Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.

  2011cites this paper
• Enhanced Toll‐like receptor (TLR) responses of TNFR‐associated factor 3 (TRAF3)‐deficient B lymphocytes

  2011cites this paper
• MIP-T3 Is a Negative Regulator of Innate Type I IFN Response

  2011cites this paper
• Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions

  2011cites this paper
• Systems biology of apoptosis and survival: implications for drug development.

  2011cites this paper
• Cranberry Proanthocyanidins Mediate Growth Arrest of Lung Cancer Cells through Modulation of Gene Expression and Rapid Induction of Apoptosis

  2011cites this paper
• The role of NF-kB2 in secondary and tertiary lymphoid tissue development

  2011cites this paper
• Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.

  2010cites this paper
• TRAF3 Controls Activation of the Canonical and Alternative NFκB by the Lymphotoxin Beta Receptor

  2010cites this paper
• In vivo analysis of the 2-Cys peroxiredoxin oligomeric state by two-step FRET.

  2010cites this paper
• A Flow Cytometry-Based FRET Assay to Identify and Analyse Protein-Protein Interactions in Living Cells

  2010cites this paper
• Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development.

  2009cites this paper
• cIAP1-dependent TRAF2 degradation regulates the differentiation of monocytes into macrophages and their response to CD40 ligand.

  2009cites this paper
• REVIEW ARTICLE Receptor Mosaics and Their Intramembrane Receptor-Receptor Interactions: Molecular Integration in Transmission and Novel Targets for Drug Development

  2009cites this paper
• Genomic and Functional Uniqueness of the TNF Receptor-Associated Factor Gene Family in Amphioxus, the Basal Chordate1

  2009cites this paper
• Apoptosis-related genes change their expression with age and hearing loss in the mouse cochlea

  2008cites this paper
• (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways.

  2008cites this paper
• Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK

  2008cites this paper
• Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.

  2007cites this paper
• Prestin–prestin and prestin–GLUT5 interactions in HEK293T cells

  2007cites this paper
• A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression

  2007cites this paper
• Multiple roles of TRAF3 signaling in lymphocyte function

  2007cites this paper
• Copper sensing based on the far-red fluorescent protein, HcRed, from Heteractis crispa.

  2007cites this paper
• Rosmarinic acid as a downstream inhibitor of IKK-beta in TNF-alpha-induced upregulation of CCL11 and CCR3.

  2006cites this paper
• TRAF6 Regulates Cell Fate Decisions by Inducing Caspase 8-dependent Apoptosis and the Activation of NF-κB*

  2006cites this paper
• Rosmarinic acid as a downstream inhibitor of IKK‐β in TNF‐α‐induced upregulation of CCL11 and CCR3

  2006cites this paper
• The KSHV oncoprotein vFLIP contains a TRAF‐interacting motif and requires TRAF2 and TRAF3 for signalling

  2006cites this paper
• The TRAF3-binding site of human molluscipox virus FLIP molecule MC159 is critical for its capacity to inhibit Fas-induced apoptosis

  2006influential citation
• BLyS and B cell homeostasis.

  2006cites this paper
• Methods to monitor the quaternary structure of G protein‐coupled receptors

  2005cites this paper
• Fluorescent proteins as a toolkit for in vivo imaging.

  2005cites this paper
• Comparison of (−)-Epigallocatechin-3-Gallate Elicited Liver and Small Intestine Gene Expression Profiles Between C57BL/6J Mice and C57BL/6J/Nrf2 (−/−) Mice

  2005cites this paper
• Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?

  2004cites this paper